Transformation Into Viatris Not Seen As The Solution Mylan Needs

Analysts Remain Concerned About Growth Prospects

 
• By Mary Jo Laffler
  
Arrows miss target
Some analysts think the new company misses the mark
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business